Clinical trial
Pharmacokinetics of Once Daily Antiretroviral Therapy Regimens Containing Tenofovir and Atazanavir/Ritonavir in Adolescents and Young Adults With HIV Infection
NCT00273273 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics of Once Daily Antiretroviral Therapy Regimens Containing Tenofovir and Atazanavir/Ritonavir in Adolescents and Young Adults With HIV Infection
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- December 31, 2007
- Enrollment
- 30
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.